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Abstract: It is increasingly clear that DNA viruses exploit cellular epigenetic processes to control
their life cycles during infection. This review will address epigenetic regulation in members of the
polyomaviruses, adenoviruses, human papillomaviruses, hepatitis B, and herpes viruses. For each
type of virus, what is known about the roles of DNA methylation, histone modifications, nucleosome
positioning, and regulatory RNA in epigenetic regulation of the virus infection will be discussed.
The mechanisms used by certain viruses to dysregulate the host cell through manipulation of
epigenetic processes and the role of cellular cofactors such as BRD4 that are known to be involved in
epigenetic regulation of host cell pathways will also be covered. Specifically, this review will focus on
the role of epigenetic regulation in maintaining viral episomes through the generation of chromatin,
temporally controlling transcription from viral genes during the course of an infection, regulating
latency and the switch to a lytic infection, and global dysregulation of cellular function.
Keywords: epigenetic; DNA virus; regulation; gene expression; histone modifications; nucleosomes;
DNA methylation; ChIP-Seq; latency
1. Introduction
The words of the Nobel Laureate Bob Dylan “Because something is happening here, but ya don’t
know what it is, do you Mister Jones?” could very well apply to our understanding of the role that
epigenetics plays in regulating viral life cycles. While there is lots of evidence that epigenetics plays a
critical role in the regulation of virus infections, in many cases the details of the role have not been
completely elucidated. While there are likely to be many factors contributing to our relative lack
of understanding of the details of viral epigenetic regulation, one of the major contributors is the
inherent complexity of epigenetic regulation. There are presently five well-characterized processes that
are thought to make up epigenetic regulation including: DNA methylation, nucleosome positioning,
histone variants, histone modifications, and regulatory RNA (Table 1). Needless to say, epigenetic
regulation has been the subject of intense interest because of its potential ability to maintain stable
gene expression when necessary with the flexibility to respond to changes in environment. Epigenetic
regulation contributes to stability by maintaining the chromatin structure of the genome from parental
to daughter chromatin during replication and by extension the gene expression patterns by what
is known as transgenerational epigenetic regulation. At the same time, each of the five epigenetic
processes are sufficiently plastic to allow for the establishment of new epigenetic states as a result of
changes in the environment such as the de novo expression of new transcription factors by generating
new chromatin structures. Because of the relatively limited coding capacity of a typical DNA virus
genome, the viruses tend to use one or more cellular biological processes to accomplish their own
molecular biology. As a result, epigenetic regulation during viral infections is usually bidirectional
between the virus and the cell. The virus will use cellular factors for transcription or replication and
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epigenetic cofactors such as histone acetylases, deacetylases, methyases, and demethylases in the
control of its life cycle, The virus may also epigenetically dysregulate cellular pathways in order to
optimize its own transcription or replication or evade the cells innate immune response.
Table 1. Functional outcomes of epigenetic regulation.
Epigenetic Process Target Function
DNA Methylation DNA in cell or viral epigenome Typically silence genes
Nucleosome Location Cellular and Viral Chromatin Nucleosome position controls access toDNA sequences
Histone Modification Cellular and Viral Chromatin
Histone acetylation and methylation on
H3K4/H3K36 association with activation of
transcription, methylation on H3K9 and
H3K27 is associated with repression,
methylation of H4K20 could result in either
activation or repression
Histone Variants Cellular and Viral Chromatin Not yet well understood for viruses
miRNA Cellular and Viral Chromatin Modify gene expression at the levelof translation
1.1. New Technology to Study Viral Epigenetics
Two relatively recent technological advances have substantially contributed to our understanding
of epigenetic regulation. The first, chromatin immunoprecipitation (ChIP) [1–3] made it possible to
determine which histone variants, histone modifications, or other proteins were bound to chromatin
isolated under specific conditions of gene expression. Combining ChIP analyses with the more recently
developed next-generation sequencing in a ChIP-Seq [4] made it possible to determine the genomic
location of nucleosomes in general and more specifically nucleosomes which contain a particular
histone variant or histone modification over a complete genome. ChIP-Seq also can be used to
determine the genomic location of proteins of interest such as the steady state binding sites for RNA
Polymerase II (RNAPII). Together, these techniques used with various model systems have led to
certain general rules with respect to the function of DNA methylation, nucleosome location, and
histone modifications.
1.2. Role of Epigenetic Regulation
DNA methylation is generally thought to be associated with repression of transcription [5].
Nucleosome location is thought to play a critical role in regulation by controlling the availability
of DNA sequences targeted by transcription factors or RNAPII [6]. Typically, a binding site will be
covered by a nucleosome during repression and uncovered during activation. The rules for histone
modifications are somewhat more complex due to the inherent complexity of histone modification.
In general, histone H3 and H4 acetylation are associated with active chromatin as is histone H3K4
methylation and H3K36 methylation [7,8]. In contrast, histone H3K9 methylation and H3K27 are
associated with repression [9–11]. Histone H4K20 methylation is somewhat more complex, having
been reported associated with both activation and repression (reviewed in [12]). With the advent of
ChIP-Seq, it is clear that these rules are actually more complex, because the position of nucleosomes in
a genome that carry either mono-, di-, or tri-methylated histone may be different, suggesting that the
pattern of methylated nucleosomes may have different functions.
1.3. Why Do Viruses Use Epigenetic Regulation?
DNA viruses, which exist as nuclear episomes (polyomaviruses, adenoviruses, papillomaviruses,
herpesviruses, and hepatitis B virus), are very likely to exploit epigenetic mechanisms to regulate
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biological activities during their life cycle for a number of reasons. First, these viruses typically exist as
chromatin either throughout their life cycle or at least when present in the nucleus of a cell. Second, the
viruses usually utilize a number of cellular regulatory factors, co-factors, and enzymes to accomplish
gene expression and its regulation. Finally and importantly, these viruses require epigenetic or similar
processes to allow the different viral genome states necessary to complete an infection to coexist.
Many DNA viruses are known to coordinately perform divergent biological processes within the same
infected nucleus of a cell. For example, at later times in a typical infection by a DNA virus one might
expect to find viral genomes replicating, transcribing one or more distinct genetic units, and also
undergoing encapsidation to form new virus particles. Each one of these distinct biological processes
would be expected to be tightly controlled relative to the other processes and yet would all be based
upon the same DNA sequence of the virus. Differences in one or more epigenetic process listed above
would allow for the coexistence of the different functional forms of the viral genome and maintain
the necessary tight control. The viruses may also epigenetically dysregulate host cell biology in order
to enhance their own biological processes. For example, they may stimulate the synthesis of factors
involved in DNA replication or transcription or alternatively inhibit pathways of immune surveillance.
This review will focus on DNA viruses which exist as episomes for at least part of their life cycle
and will update a prior publication [13] with data which has been published since January 2015. It will
focus primarily on members of the polyomavirus, adenoviruses, papillomaviruses, herpesvirus, and
hepatitis B virus all of which have been relatively extensively studied to date. Since many of these
viruses also appear to affect their target cells by disruption of cellular epigenetic regulatory pathways,
this aspect of epigenetics will also be addressed.
2. Polyomaviruses—Simian Virus 40
The polyomaviruses are a family of small (<10 kb) double-strand closed-circular DNA tumor
viruses [14,15]. Based upon work with Simian Virus 40 (SV40), a well-studied member of this family,
it has been established that the viruses exist as typical eukaryotic chromatin when found in the nucleus
of infected cells and in the virus particle. Because the genome of these viruses is organized into
chromatin, it seemed likely that the viruses would undergo the typical forms of epigenetic regulation.
Using SV40 as a model for the family, it has been shown that the viruses undergo almost all of the
same forms of epigenetic regulation as cellular chromatin, including nucleosome location [16], histone
modifications [17,18], and miRNAs [18]. However, polyomaviruses do not appear to utilize DNA
methylation as a form of epigenetic regulation due to their small size and relative absence of target sites
for methylation. However, it is possible that an infection by a polyomavirus could result in methylation
of cellular DNA. To date, there have been no studies addressing epigenetic changes to the cell following
infection by SV40 or mouse polyomavirus. Like SV40, mouse polyomavirus has also been shown to
undergo histone modification [19]. Because the SV40 genome exists as chromatin throughout its life
cycle epigenetic regulation is likely involved in all aspects of its molecular biology. This likely includes
regulatory information in the chromatin of the virus to direct the establishment of a new infection as
well as regulating the relative levels of early and late transcription, the proportion of minichromosomes
entering replication, and ultimately the removal of minichromosomes by encapsidation.
Interestingly, epigenetic regulation of SV40 was first identified in the late 1970s, although the
changes in nucleosome positioning around the SV40 promoter [20–25] and histone modification by
acetylation [26,27] were not recognized as epigenetic regulation at the time. More recently, SV40 has
been used as a model system to study basic aspects of epigenetic regulation and the role of epigenetics
in regulating the SV40 life cycle focusing primarily on changes in histone modifications [17,18,28–36].
While informative, these studies did not yield a complete picture of regulation because they were
based primarily on the association between biological events and the changes in histone modifications.
They were also limited because they did not address the important relationship between nucleosome
positioning and histone variants or modifications.
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In order to address these two issues we have taken a three-stage approach. In the first stage, we
have determined the global location of nucleosomes in SV40 chromatin isolated at different times
in infection and from virus particles using micrococcal nuclease to prepare sequencing libraries and
next generation sequencing (NGS). This recently published work [37] will be discussed in more detail
below. In the second stage we are using ChIP-Seq with SV40 chromatin isolated at 48 h post-infection
and from virus particles to determine the global location of nucleosomes which contain specific
histone tail modifications including hyperacetylated H3, hyperacetylated H4, H3K4me1, H3K4me2,
H3K4me3, H3K9me1, H3K9me2, H3K9me3, and H4K20me1. We have previously shown that all of
these histone tail modifications are present in SV40 chromatin. Since these studies are in progress,
we will only briefly describe them. While these first two stages have yielded or are yielding very
interesting results concerning nucleosome positioning and their related histone modifications, the
studies have utilized mixed populations of SV40 chromatin naturally present at the time that the
chromatin was isolated. Because this chromatin is inherently heterogeneous, it is still difficult to
ascribe specific elements of chromatin structure to specific biological activities. In the third stage, we
will use a strategy that we previously developed to determine the location of nucleosomes containing
specific histone tail modifications in specific forms of biologically active SV40 chromatin including
transcribing, replicating, and encapsidating chromatin. We will briefly describe this strategy and its
utility at the end of this section.
SV40 chromatin was analyzed for the location of all nucleosomes on the SV40 genome using
micrococcal nuclease to generate nucleosome-sized fragments of DNA. Because of the large number
of reads that can be obtained from SV40 chromatin, the data was analyzed without having to bin the
reads, which allowed for mapping to the genome with essentially single base resolution. Based upon
this analysis of global nucleosome positioning, a model was proposed in which nucleosomes play a
critical role in regulating transcription during the SV40 life cycle. In chromatin from virus particles,
nucleosomes were observed to be present at nt 5223 and nt 363 effectively covering the major early and
late start sites for transcription. In contrast, in chromatin from minichromosomes isolated at 30 min
and 48 h post-infection, nucleosomes were found at nt 5119 and nt 212, exposing the early and late
start sites. The inhibition of transcription by the nucleosomes blocking the early and late transcription
start sites was further confirmed by analyzing the SV40 mutant cs1085. This mutant lacks T-antigen
binding Site I and as a consequence does not downregulate early transcription. If the nucleosome
located at nt 5223 was involved in blocking early transcription one would expect to see that, in the
mutant, the nucleosome would be absent. Interestingly, both the nucleosome at nt 5223 and the one
located at nt 363 were substantially reduced on the SV40 chromatin in the mutant. While this was
consistent with the expectation for the early transcription it was unexpected that the late start site
would also be affected [37]. This regulatory model is shown in Figure 1.
In addition to the changes in the promoter/regulatory region of SV40, changes in the nucleosome
location around the 5′ end of the early splice site, nt 4885, and near the termination of transcription,
nt 2800–2900 were also observed in this study. The significance of these changes were not further
explored in the publication [37]. Nucleosome positioning near the termination of transcription and in
translation control regions has previously been observed in cellular chromatin (reviewed in [38]) but
not in viral chromatin.
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In the second stage of our studies we are mapping onto the SV40 genome the location of
nucleosomes present in SV40 minichromosomes and virions, which contain each of the histone
modifications described above. From this analysis, we expect to answer a number of questions
related to nucleosome organization and regulation. First, we will determine whether there are
preferred locations on the genome for nucleosomes containing each of the specific tail modifications.
If, as expected, preferred locations are found for one or more of the histone modifications, we will
then characterize the relationships between each preferred location, the underlying DNA sequences,
and the location of all nucleosomes as determined in our recent publication [37]. This will allow us to
determine whether the nucleosomes which we have identified recently which appear to regulate early
and late transcription by their presence or absence carry specific histone modifications, which could
contribute to how their presence is regulated. This analysis will also allow us to determine whether
the preferred location of a particular histone modification corresponds to the preferred location of any
other modification or whether preferred locations are associated with distinct nucleosome locations.
The third stage of these studies is based upon the strategy shown in Figure 2, which, we have
previously used successfully to identify histone modifications in SV40 chromatin which is bound
by RNA Polymerase II (RNAPII) [31–33] or replication-associated proteins [34]. In these future
studies, we will determine the location of nucleosomes containing modified histones in transcribing
minichromosomes. Transcribing SV40 minichromosomes are being immune-selected with antibody to
RNAPII as in a typical ChIP. Following sonication of the bound chromatin, the agarose containing the
chromatin fragments bound with RNAPII antibody are separated from the fragments lacking RNAPII.
The latter are then subjected to a second ChIP with an antibody to a histone modification of interest.
In our initial studies we are using antibody to hyperacetylated H3 and hyperacetylated H4 since we
have previously shown that chromatin fragments containing these modified histones are present in
SV40 minichromosomes also containing RNAPII [31,32].
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3. Other Polyomaviruses
None of the other polyomaviruses—such as John Cunningham (JC) virus, BK virus, or Merkel cell
virus—have been studied to the same extent as SV40 with respect to epigenetic regulation. Since the
viruses are similar to SV40 they are likely to use epigenetics in the same way to regulate infection
and the various functional forms of the viral minichromosome. There has been recent progress in
investigating the epigenetics of these viruses with respect to miRNAs, histone modification, and the
epigenetic reader, BRD4, primarily in explaining how these viruses may dysregulate infected cells.
Many if not all polyomaviruses contain a miRNA in the late message strand which can be cleaved
to yield a miRNA which inhibits expression of the early genes (reviewed in [39]). This miRNA
shares sequence homology with certain cellular miRNAs and it has been suggested that the miRNA
could dysregulate cellular genes as well [39]. Two recent publications support this suggestion [40,41].
The former presents evidence for the transfer of JC virus miRNA in exosomes from infected cells
to uninfected cells while the latter demonstrates a link between miRNA production by raccoon
polyomavirus and the development of tumors in animals.
A role for global dysregulation of histone modification in cancers following transformation by
Merkel cell polyomavirus has also been recently described [42]. A strong correlation was found
between tumors that expressed the large T-antigen of Merkel Cell virus and repression of H3K27
trimethylation (H3K27me3). Because repression of H3K27me3 would be associated with increased
transcription of normally silenced genes, the results suggested that Merkel cell virus could have its
tumorigenic effect through this global dysregulatory pathway in susceptible cells.
BRD4 is thought to serve as a scaffold for activating transcription by binding to acetylated lysines
present on histones in chromatin regions available for transcription and also binding to transcription
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factors necessary to initiate transcription. The function of BRD4 in the reactivation of JC virus in glial
cells was investigated using either a BRD4 inhibitor or by mutating lysines targeted for acetylation by
BRD4 on the transcription factor NF-κB p65 [43]. Since both the BRD4 inhibitor and the mutations
blocked transcription of the early genes and reactivation of infection, epigenetic regulation by histone
acetylation appears to play a critical role in the regulation of early JC virus transcription.
4. Adenovirus
The adenoviruses are a family of double-strand linear DNA viruses approximately 35 KB in
length [44]. Within the virus particle adenovirus DNA is associated with a viral protein called protein
VII which is a basic histone-like protein (reviewed in [45]). Protein VII appears to serve as a histone
substitute to compact the adenovirus DNA in the virus particle. It is generally thought that following
infection, the protein VII is replaced at least partially if not totally on the adenovirus genome by cellular
histones. Because of its relatively large size and apparent absence of chromatin in the virus particle, it
seems likely that the primary function of epigenetics is to regulate the various intracellular aspects of
the virus life cycle. Although there are no ChIP-Seq based publications to date demonstrating this,
there are several laboratories working on this subject.
The recent adenovirus publications focusing on epigenetics have addressed epigenetic effects
on the host cell as a consequence of infection [44–47]. These studies can be divided into those that
address global effects on cellular epigenetics and those that are specific to the effects of protein VII.
The global effects on histone modifications were addressed using a mass spectrometry (MS) approach
to identify post-translational histone modifications [48]. Infected cells were isolated at different times
during infection and the histones prepared for MS analysis. The analysis demonstrated that there
were distinct global changes in histone modifications during the course of an infection. However, the
technique did not allow for the localization of the changes to specific genes.
The global effects on cellular transcription and histone modifications was also analyzed using the
adenovirus early regulatory protein E1A wild-type and mutant viruses in the context of infection [47].
In this study, ChIP-Seq was used to identify the target genes, which underwent significant changes
in transcription as measured by changes in histone acetylation. A number of genes, which would
normally be expected to inhibit infection, were found to be repressed by E1A expression [47].
Our understanding of the epigenetic role of adenovirus protein VII was recently extended in a
publication combining biochemistry, cell biology, and mass spectrometry [48]. Protein VII was shown
to function in a manner similar to epigenetic readers by binding to high mobility group (HMG) proteins
to prevent the loss of the HMG proteins from nucleosomes. Interestingly, the binding to nucleosomes
was also dependent upon the post-translational modifications of protein VII again showing similarities
to cellular epigenetic regulators [48].
5. Human Papillomaviruses
The human papillomaviruses (HPV) are a family of closed-circular double-stranded DNA viruses
with an approximately 8000 bp genome [44]. Because of the similarity between HPV and the
polyomaviruses with respect to their physical structure and genetics, HPV would also be expected
to contain typical chromatin structure throughout its life cycle and to be regulated epigenetically.
However, for technical reasons associated with its complex life cycle it has been much harder to study
the role of epigenetics of the virus in a lytic infection and consequently there is much less known
about the epigenetics of infection. The technical difficulties associated with studying the HPV life
cycle result from the fact that the life cycle is regulated by the normal differentiation process of the
infected epithelial cells. Since this is generally studied in relatively small raft cultures, it has been very
difficult to obtain sufficient materials at different stages of the life cycle to study. There are examples of
transformed cells derived from cancers in which the HPV exists as a nonintegrated episome, which
can be studied, but in general it is not clear that epigenetic regulation in these examples necessarily
mirror the normal processes which occur in a lytic infection.
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Because HPV is a very important human pathogen causing a number of different types of
cancer there is much more known about the role of epigenetics in the transformation of normal
cells and in cancers. This role has been recently reviewed and will not be discussed in detail [49].
Not surprisingly, HPV appears to dysregulate a number of epigenetic processes during transformation
and cancer including DNA methylation, histone modification, chromatin remodeling, and miRNAs [49].
Epigenetic dysregulation can occur either on cellular genes or on the viral genes, particularly when the
virus is integrated into the host genome. Not unexpectedly, the primary transforming proteins—E6
and E7—play a major role in much of the known dysregulation.
Despite the difficulties associated with studying epigenetic regulation in HPV lytic infections
there has been some notable recent work [50–58]. By characterizing the effects of dysregulation of the
deactylase, Sirtuin 1, a role for histone acetylation during HPV replication was established [50]. A role
for acetylation during the HPV life cycle coordinating with cell differentiation was observed following
studies of TIP60, an acetyltransferase [51]. A role for BRD4, the chromatin reader—which binds
acetylated histones in the activation of early HPV transcription—has also been established [52–55].
Together, these results suggest that histone acetylation is likely to occur during the HPV life cycle with
functions similar to what is occurring in cellular epigenetic regulation. There is also evidence that
histone methylation occurs during the HPV life cycle. The human interferon-inducible protein IFI16
appears to inhibit HPV replication and transcription and in part this may be occurring through the
introduction of histone methylation marks previously associated with repressive cellular chromatin [56].
Finally, the CCCTC-binding protein (CTCF) has been shown to affect transcription from the HPV early
region during lytic infection by binding to a site in the E2 open reading frame [57]. Although CTCF is
not generally considered one of the typical epigenetic regulatory factors like histone modifications, it
appears to play a role in regulating transcription by directly interacting with chromatin in a number of
viruses including HPV [58].
6. Hepatitis B
Hepatitis B virus (HBV), a significant human pathogen, exists as a 3.2 kb single strand of DNA
in the virus particle and as a covalently closed circular DNA (cccDNA) in the infected nucleus of a
cell [15]. Not surprisingly, the cccDNA associates with histones and other cellular proteins to form
a minichromosome in the infected cell [59]. Because there was a recent extensive review [60] of
HBV epigenetics, this section will only focus on two aspects that are likely to be the basis for many
future studies.
Using a modified ChIP-Seq procedure with enhanced sensitivity, the location of nucleosomes
containing specific histone modifications and RNA PII were mapped to the HBV genome in cccDNA
chromatin [61]. These studies showed that the HBV minichromosome contained nucleosomes and
histone modifications similar to those seen in cellular chromatin such as H3K4me3 located near
enhancer regions and acetylated histones in transcribed regions. Moreover, there were certain
differences observed when comparing the organization of HBV chromatin from different infected
sources, suggesting that the chromatin structure of the minichromosome was reflecting the epigenetic
milieu of the infected cell to some extent. Because HBV DNA becomes chromatin upon infection the
virus does not appear to be capable of transgenerational epigenetic memory. For this virus, epigenetic
regulation appears to be required to control the relative proportion of mRNAs corresponding to the
entire genome for its replication and the viral proteins needed for other aspects of its life cycle. Because
of its significance as a human pathogen, these studies are likely to serve as the basis for subsequent
investigations directed further characterization of HBV epigenetic regulation with the intention of
identifying targets for therapeutic intervention.
Similarly, it seems very likely that there will be further studies on the role of the HBV protein HBx
which appears to function as an epigenetic regulator to dysregulate a number of cellular genes as well
as regulate the virus (reviewed in [62]). HBx appears to dysregulate a number of cellular pathways in
part by binding to genomic DNA [63], changing expression patterns of miRNAs [64], affecting histone
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methyltransferases [65], binding to SIRT1 to activate transcription [66], and cooperating with histone
methylases and demethylases to change the cell expression pattern [67].
7. Herpesviridae
Herpesviridae are a family of relatively large double-strand DNA viruses approximately 160 kb in
size [15]. Because a number of the members of this family are significant human pathogens—including
herpes simplex virus (HSV), Epstein–Barr virus (EBV), and Kaposi’s sarcoma-associated herpesvirus
(KHSV)—the regulation of the life cycles of these viruses has been extensively studied. As a result, there
have been a number of recent reviews focusing on epigenetic regulation in these viruses. The reader is
encouraged to consult these reviews for a detailed description of regulation including dysregulation of
host cells by a particular virus.
There are two aspects of the life cycle of the typical herpesvirus which are particularly relevant
to epigenetics [68]. The first is the circularization and chromatinization of the linear viral DNA upon
infection and entry into the nucleus of a cell. The second is the regulation of the choice between a
latent and a lytic infection following infection by these viruses. The formation of chromatin structure
on infecting viral DNA is a critical first step in ensuring that only relevant early gene expression
occurs during the initial stages of infection. Since viral DNA contains a large number of genes with a
corresponding number of promoters, without the formation of chromatin it is unlikely that only the
early viral genes would be expressed.
Depending upon the cellular environment, infection by herpesviruses can result in either a lytic
infection, in which, the infected cell is ultimately killed, or a latent infection in which the virus exists
as an episome (minichromosome) stably in the nucleus of the infected cell. To exist as a stable episome,
the virus must be able to coordinate its own replication with that of the cell and to segregate itself along
with the chromosomes of the cell following replication. This aspect of regulation is generally controlled
by a viral protein, which interacts with the cellular chromosomes to tether the newly replicated virus
for segregation along with the chromosome. Each of the viruses has its own multifunctional protein to
accomplish this. Finally, there must be a way for the virus present in a latent infection to reactivate to
generate a lytic infection usually as a result of a change in the cellular environment. Epigenetics is
thought to contribute to all of these processes.
KSHV has been extensively studied because of its ability to cause cancer in AIDS patients.
There are recent reviews that the reader is encouraged to consult for details on the role of epigenetic
regulation in this virus [69–71]. Epigenetic regulation of this herpes virus can be considered a model for
all of the viruses. Upon infection, the linear DNA is circularized and chromatinized relatively quickly.
The chromatin structure initially is organized to allow for immediate–early transcription [70] with
corresponding histone modifications activating the appropriate genes and deactivating other genes.
The critical RTA transcription factor which is involved in activating the lytic form of the virus is
repressed shortly after infection but placed into a bivalent chromatin state containing both activating
and repressive histone modifications. Latency Associated Nuclear Antigen (LANA), the latency
regulator [71] is produced along with a small number of other early gene products and together are
responsible for maintaining the latent state through replication and episome segregation along with
cellular chromosomes. LANA functions in part by binding to the viral DNA and also to cellular
chromatin [71]. Upon reactivation of the viral episome, there is a gross change in chromatin structure
consistent with the activation of the late viral genes necessary for the completion of the virus life cycle
and the synthesis of new virus particles [70]. In KSHV, there is also evidence that over time gene
silencing in repressive chromatin may also occur through DNA methylation and interactions with
noncoding RNAs [69].
Both HSV and EBV seem to be epigenetically regulated similarly to KSHV although the viral
proteins responsible for the regulation are unique to the other viruses. In lytic infections, HSV viral
DNA is chromatinized within 1–2 h of infection and the chromatin is acted upon by transcription
factors from the virus and cell along with chromatin remodeling factors to initiate immediate–early
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gene expression (reviewed in [68,72]). The chromatin modifications include changes in histone
modification and nucleosome positioning. In contrast in cell, which support a latent infection,
chromatization appears to occur much more slowly and the genes responsible for completion of a lytic
infectious cycle appear to exist as heterochromatin with typical histone modifications characteristic of
heterochromatin [68,72]. The epigenetic regulation of EBV has been of particular interest because of
EBV’s role in causing certain human cancers. Because of this, it has undergone some very extensive
analyses including a characterization of the location of all of the typical histone tail modifications, the
binding sites for a number of common transcription factors, and RNAPII on the EBV genome [73].
The results of these analyses were generally consistent with the reported associations between certain
histone modifications and gene expression or repression. For example, methylated H3K4 was located
at sites of gene expression and the location of RNAPII. However, the results were also somewhat
confusing since repressive modifications were also associated with some of these sites [73]. The results
suggested that there might be more heterogeneity and dynamic modification taking place in the
viral chromatin. An overview of epigenetic regulation of EBV, including DNA methylation and
other cellular processes, has also appeared recently [74]. In general, DNA methylation of the EBV
genome, like its cellular counterpart, occurs to silence genes. However, there are significant differences
within various latency types with respect to the genes silenced [74]. A role for CTCF in the epigenetic
regulation of EBV has also been established. CTCF appears to prevent the spread of repressive histone
modifications into genomic regions, which would normally be activated for transcription [74]. Finally,
the review discusses the epigenetic dysregulation of the host cell genome as might be expected for a
virus infection.
8. Future Research Directions
Our understanding of epigenetic regulation is poised for significant advancement in the next
few years. One way, this will be occurring is by moving away from interpretation by association to a
more mechanistic view of regulation. As described above, much of what we know about epigenetic
regulation is based upon studies, which can only show that a particular epigenetic regulatory change
is associated with an activating or repressive biological event. For example, a comparison between
the chromatin structure of a silent gene and its active counterpart shows the changes associated
with activation. This has led to some of the general regulatory rules described above, such as the
observation that methylated H3K4 is associated with gene activation. Recent studies with ChIP-Seq
have shown that at best this is an overly simplistic view of the role of histone modification. What is
lacking in many cases is exactly how and why a particular modified histone or similar epigenetic change
contributes to a biological event like the activation or repression of a specific gene. This is made more
evident in the studies described in which the locations of various histone modifications are mapped
to nucleosomes in chromatin. While the technology to address epigenetic mechanisms is probably
available at this time, it is likely that new strategies will need to be developed to study mechanisms.
This may entail new model systems, which can be exploited in vitro.
A second area where progress is likely to occur is in better understanding the relationship
between the location of nucleosomes containing specific histone modifications and the binding of
regulatory factors. As indicated above, some of the results to date are paradoxical. For example, in
SV40, T-antigen binding to Site I results in the introduction of a nucleosome which is located essentially
in the same position as Site I. It is difficult to imagine how both T-antigen and the nucleosome can
occupy the same location in the same chromatin given our knowledge of how each binds to DNA.
Similarly, in Hepatitis B Virus, RNAPII binds to its promoter at a site, which is overlapped by a
nucleosome containing H3K4me1. Again, it is not clear how the RNAPII can bind to its target DNA if
the site is also being occupied by a nucleosome.
Studies on the epigenetic regulation of DNA viruses will continue to be of significant interest for
a number of reasons. First, their dependence on host cell proteins and processes for their molecular
biology means that they can serve as useful models for cellular epigenetic events. More importantly,
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because of their general small size and ease of genetic and other forms of manipulation, they may serve
as the chromatin substrates for the in vivo and in vitro studies needed to unravel the mechanisms
involved in epigenetic regulation. Importantly the relatively small size of these viruses and the
relatively large amounts of chromatin that can be obtained by infection, makes ChIP-Seq and similar
NGS analyses cost effective. In addition, the high resolution, which can be obtained from the analysis
of these viruses, will also be important for the mechanistic studies. As indicated above with SV40
we can obtain single base resolution in our ChIP-Seq studies. With this high resolution, it is possible
to further characterize the small shifts in nucleosome location, which our group and others have
recently observed.
A better understanding of the mechanisms responsible for the introduction of epigenetic
information and, correspondingly, the mechanisms responsible for reading this information may
possibly lead to novel treatments for infections by these viruses many of which are serious
human pathogens. Characterizing the mechanisms that underlie each form of epigenetic regulation
and dissecting the complex interplay between viral DNA sequences may identify viral proteins and
cellular contributors that will lead to new targets for therapeutic intervention.
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